B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

282.07 +3.53 (+1.27%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
1 High-Flying Stock on Our Watchlist and 2 Facing Challenges
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,... 
Via StockStory
Topics Economy
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q3 Earnings Call
West Pharmaceutical Services delivered third quarter results that surpassed Wall Street’s revenue and profit expectations, sparking a strong positive reaction in the market. Management attributed this... 
Via StockStory
Topics Earnings
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
Earnings Scheduled For October 23, 2025
 
Via Benzinga
These S&P500 stocks are moving in today's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
Demystifying West Pharmaceutical Servs: Insights From 5 Analyst Reviews
 
Via Benzinga
WST Q3 Deep Dive: GLP-1 Demand, Annex 1 Upgrades, and Margin Expansion Shape Outlook
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The... 
Via StockStory
Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday
The company crushed analyst profitability estimates, both for its trailing quarter and for its full-year guidance. 
Via The Motley Fool
Why Are West Pharmaceutical Services (WST) Shares Soaring Today
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 12.3% in the afternoon session after the company reported strong third-quarter 2025 results that surpassed analyst... 
Via StockStory
Topics Artificial Intelligence Earnings Supply Chain
Thursday's session: top gainers and losers in the S&P500 index
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
WST Stock Soars After Company Raises Full-Year Guidance On Strong Demand For GLP-1 Drug Components
The Pennsylvania-headquartered company raised its full-year net sales guidance to $3.06 billion to $3.07 billion, up from $3.04 billion to $3.06 billion. 
Via Stocktwits
Topics Artificial Intelligence Earnings
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Thursday's session. 
Via Chartmill
Oil Stocks Rally On Trump's Russia Sanctions: What's Moving Markets Thursday?
Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp rebound in crude prices and lifted energy shares. 
Via Benzinga
Topics Government
Discover which S&P500 stocks are making waves on Thursday.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand
West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP component growth. 
Via Benzinga
These S&P500 stocks are gapping in today's session
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Thursday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Topics Stocks
Wondering what's happening in today's S&P500 pre-market session?
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment. 
Via Chartmill
West Pharmaceutical Services (NYSE:WST) Q3 2025 Earnings Top Estimates, Boosts Full-Year Outlook
West Pharmaceutical Services (WST) beats Q3 2025 earnings and revenue estimates, raises full-year guidance. The strong results, led by an EPS beat, sent the stock up over 6% pre-market. 
Via Chartmill
West Pharmaceutical Services’s (NYSE:WST) Q3 Sales Beat Estimates
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The... 
Via StockStory
Topics Earnings Economy
West Pharmaceutical Servs's Earnings Outlook
 
Via Benzinga
West Pharmaceutical Services (WST) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday morning. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
3 Cash-Producing Stocks That Fall Short
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Topics Economy
1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Turn Down
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Topics Economy
3 Healthcare Stocks We Keep Off Our Radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Economy Stocks
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Deep Dive Into West Pharmaceutical Servs Stock: Analyst Perspectives (5 Ratings)
 
Via Benzinga
3 Reasons to Avoid WST and 1 Stock to Buy Instead
West Pharmaceutical Services has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 16.3% to $260.31 per share while the... 
Via StockStory
Topics Stocks
Bill Gates Bets Big on Buffett: A Defensive Play Amidst Tech Uncertainty?
In a significant shift that has caught the attention of financial markets and online communities alike, Bill Gates, through his investment vehicle Cascade Investment, has made notable adjustments to... 
Via MarketMinute
Topics Economy
Looking Into West Pharmaceutical Servs's Recent Short Interest
West Pharmaceutical Servs's (NYSE: WST) short interest as a percent of float has risen 9.25% since its last report. According to exchange reported data, there are now 1.68 million shares sold short,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.